CYTOMX THERAPEUTICS INC (CTMX) Stock Balance Sheet
NASDAQ:CTMX • US23284F1057
Current stock price
4.245 USD
-0.21 (-4.82%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 12.67M | 38.05M | 17.17M | 193.70M | 205.50M | |||
| Marketable Securities | 124.39M | 62.57M | 157.34M | 0.00 | 99.70M | |||
| Receivables | 2.01M | 3.10M | 3.43M | 36.00M | 800.00K | |||
| Other Current Assets | 4.86M | 3.58M | 5.00M | 7.50M | 4.30M | |||
| Total Current Assets | 143.92M | 107.31M | 182.94M | 237.10M | 310.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.70M | 10.60M | 16.18M | 21.00M | 25.30M | |||
| Goodwill | 949.00K | 949.00K | 949.00K | 900.00K | 900.00K | |||
| Intangibles | 438.00K | 583.00K | 729.00K | 900.00K | 1.00M | |||
| Other Non-Current Assets | 1.56M | 1.09M | 1.00M | 900.00K | 1.80M | |||
| Total Non-Current Assets | 7.64M | 13.23M | 18.86M | 23.80M | 29.10M | |||
| TOTAL ASSETS | 151.57M | 120.53M | 201.79M | 260.90M | 339.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 18.41M | 17.48M | 22.19M | 26.90M | 34.20M | |||
| Accounts Payable | 1.30M | 1.09M | 1.46M | 2.80M | 2.80M | |||
| Other Current Liabilities | 26.90M | 67.20M | 132.27M | 122.90M | 40.80M | |||
| Total Current Liabilities | 46.62M | 85.77M | 155.91M | 152.60M | 77.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 5.94M | 35.22M | 93.33M | 194.00M | 262.00M | |||
| Total Non-Current Liabilities | 5.94M | 35.22M | 93.33M | 194.00M | 262.00M | |||
| TOTAL LIABILITIES | 52.56M | 120.99M | 249.24M | 346.60M | 339.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -711.95M | -691.58M | -723.45M | -722.90M | -623.60M | |||
| Additional Paid In Capital | 810.84M | 691.10M | 675.90M | 637.10M | 623.30M | |||
| Common Shares | 2.00K | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 111.00K | 27.00K | 95.00K | 0.00 | -200.00K | |||
| Shares Outstanding | 170.19M | 80.10M | 67.31M | 66.20M | 65.40M | |||
| Tangible Book Value per Share | 0.57 | -0.02 | -0.73 | -1.32 | -0.04 | |||
| Total Shareholders' Equity | 99.01M | -456.00K | -47.45M | -85.80M | -500.00K | |||
| TOTAL LIABILITIES AND EQUITY | 151.57M | 120.53M | 201.79M | 260.90M | 339.40M | |||
| Statistics | ||||||||
| Current Ratio | 3.09 | 1.25 | 1.17 | 1.55 | 3.98 | |||
| Return On Assets (ROA) | -13.44% | 26.44% | -0.28% | -38.06% | -34.15% | |||
| Return On Equity (ROE) | -20.57% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital (ROIC) | N/A | 56.81% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21